Filma Utama Soap Pt

What Filma Utama Soap Pt does

Filma Utama Soap Pt is an Indonesian legal entity operating within the Tempo Scan Group (PT Tempo Scan Pacific Tbk), a publicly listed Indonesian pharmaceutical, consumer goods, and cosmetics company founded in 1953 and listed on the Indonesia Stock Exchange under ticker TSPC. The group manufactures, markets, and distributes more than 30 brands across three core segments — Healthcare (e.g., Bodrex, Vidoran, Contrexyn, Oskadon), Consumer Products (e.g., MyBaby, Hemaviton, Natural Honey, Total Care), and Cosmetics (e.g., Marina, Ultima II, Claudia, Tamara) — alongside a Prescription Pharmaceuticals line. Operations are vertically integrated, with in-house Manufacturing Facilities and a dedicated internal Distribution Services division supplying the Indonesian market nationally, complemented by an International Business export arm and the Tempo Aurora Sehat Clinic healthcare service offering.

Revenue mechanics are anchored in mass-market B2C sales of branded OTC medicines, consumer personal care, nutritional supplements, and beauty products to Indonesian consumers, with secondary revenue from export markets and prescription pharmaceuticals. Go-to-market relies on the company's own distribution infrastructure rather than third-party logistics, and brand equity built over more than 70 years is the primary commercial asset. Strategic activity in 2025–2026 includes multiple corporate recognitions (Forbes Asia Best Under a Billion 2025, Indonesia Most Reputable Companies 2025, IMECO 2025, Investortrust Awards 2025 in Healthcare) and, most significantly, a joint venture agreement signed in July 2026 with Chia Tai Tianqing Pharmaceutical Group Co., Ltd (CTTQ), a subsidiary of Sino Biopharmaceutical Limited, aimed at expanding international pharmaceutical operations.

Name

Filma Utama Soap Pt

Legal name

PT Tempo Scan Pacific Tbk

Website

https://thetempogroup.net

Company type

Public

Founded year

1953

Operating status

Operating

Headcount range

11–50 employees

Short description

Filma Utama Soap Pt operates within Indonesia's Tempo Scan Group, a publicly listed manufacturer and distributor of more than 30 pharmaceutical, consumer, and cosmetic brands (including Bodrex, Vidoran, and Marina) serving mass-market Indonesian consumers via integrated manufacturing and nationwide distribution.

Ownership category

akta.pro rank

Product category

Consumer Goods & Pharmaceuticals

NAICS

Soap and Cleaning Compound Manufacturing (32561), Soap and Other Detergent Manufacturing (325611), Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Bath & Shower Products (Soaps, Body Wash, Bath Additives) (CRADANAB)

Keywords

• Pharmaceutical manufacturing
• Consumer goods production
• Cosmetics and personal care
• OTC healthcare products
• Baby care products

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels1 record

Core offering

Filma Utama Soap Pt is a manufacturing entity within Tempo Scan Group that produces pharmaceutical, consumer, and cosmetics products under well-known Indonesian brands such as Bodrex, Vidoran, Marina, MyBaby, and Oskadon. The company supports the group's vertically integrated operations spanning in-house manufacturing, brand marketing, and Indonesia-wide distribution, with additional international export business and a partnership with CTTQ (Sino Biopharmaceutical). Filma Utama Soap Pt itself operates as a small manufacturing unit (19 employees) based in Surabaya, East Java.

Product overview

Tempo Scan Group operates a diversified pharmaceutical and consumer products portfolio through multiple business segments: Healthcare (OTC medications like Bodrex, Vidoran, Contrexyn), Consumer (personal care, baby products like MyBaby, nutritional supplements like Hemaviton), Cosmetic (beauty products including Ultimall and Marina Glow Ready), Prescription pharmaceuticals, Distribution Services, Manufacturing Facilities, and International Business. The company has over 70 years of experience and holds market leader positions in Indonesia for its pharmaceutical products.

Differentiator

Problem solved

Functional benefit

Brands

• Vidoran: Consumer health and wellness brand
• Bodrex
• Contrexin
• Oskadon
• Neorheumacyl
• Contrex
• Bodrexin
• Marina
• Oskadryl
• Neodulax
• Sudrex
• Allercyl
• Natural Honey
• Claudia
• Tamara
• MyBaby
• MyBabyKids
• PureBaby
• SOS
• Ultima II
• Marina GlowReady
• Oralinu
• Wybert
• Bodrexin Herbal
• Herbalax
• Natural Choice
• Total Care
• Hemaviton
• Neohormoviton
• Polaris
• Vitonal
• IPI

Products and services

• Healthcare Products (OTC) Over-the-counter pharmaceutical products including pain relief, respiratory, digestive, and general health medications, marketed under long-standing Indonesian brands such as Bodrex, Oskadon, Contrexyn, Neorheumacyl, Bodrexin, Allercyl, and Sudrex. Targeted at Indonesian mass-market consumers for self-medication.
• Consumer Products Consumer goods portfolio covering personal care, baby care, nutrition supplements, and wellness products under brands such as Vidoran, MyBaby, MyBabyKids, PureBaby, Hemaviton, Neohormoviton, Total Care, Natural Honey, Natural Choice, SOS, Oralinu, Wybert, Polaris, Vitonal, IPI, and Herbalax. Targeted at Indonesian households and parents.
• Cosmetic Products Cosmetic and beauty products including skincare and makeup marketed under brands such as Marina, Marina Glow Ready, Ultima II, Claudia, and Tamara. Targeted at Indonesian consumers seeking beauty and skincare products.
• Prescription Products Prescription-only pharmaceutical products for regulated medical treatments, distributed via healthcare and pharmacy channels.
• Distribution Services In-house distribution services division providing logistics and distribution of pharmaceutical and consumer products across Indonesia, available as a partnership channel to enterprises.
• Manufacturing Facilities / Services Manufacturing capabilities for pharmaceuticals, consumer products, and cosmetics, providing integrated production and economies of scale for Tempo Scan Group's portfolio.
• International Business (Export) International business operations and export services for Tempo Scan Group's product portfolio across Southeast Asia, expanded via the July 2026 joint venture with CTTQ.

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Chia Tai Tianqing Pharmaceutical Group Co., Ltd (CTTQ)coreStrategic or Co-development Partner · 1 July 2026Joint venture agreement signed in July 2026 between Tempo Scan Group and Chia Tai Tianqing Pharmaceutical Group Co., Ltd (CTTQ), a subsidiary of Sino Biopharmaceutical Limited. This represents a significant strategic partnership in the pharmaceutical sector.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Regional players

• PT Sinergi Inti Andalan (SIA) / Other CTTQ peers: Chia Tai Tianqing Pharmaceutical (CTTQ), the JV partner under Sino Biopharmaceutical Limited, is itself a comparable Chinese pharma player that shares Tempo Scan's prescription and OTC pharma business model, useful as a benchmark for the scale and value of the partnership.

Direct peers

• PT Mandom Indonesia Tbk: Japanese-affiliated Indonesian personal-care and cosmetics company (e.g., Gatsby, Pixy) competing in overlapping personal-care and cosmetics categories with Tempo Scan's consumer segment.
• PT Mustika Ratu Tbk: Long-established Indonesian cosmetics, herbal, and personal-care company with overlapping herbal and beauty product lines, competing in similar traditional and modern Indonesian retail channels.
• PT Industri Jamu dan Farmasi Sido Muncul Tbk: Listed Indonesian herbal pharmaceutical and consumer health company (e.g., Tolak Angin, Kuku Bima) that overlaps with Tempo Scan's herbal and OTC franchises such as Bodrexin Herbal and Herbalax, targeting the same Indonesian mass-market consumer.
• PT Kalbe Farma Tbk: Indonesia's largest pharmaceutical and consumer health company, competing directly with Tempo Scan's OTC and prescription pharma portfolio (e.g., Bodrex vs. Kalbe's analgesics) and operating a similar multi-brand CPG model across prescription drugs, consumer health, and nutrition.
• PT Deltomed Laboratories: Indonesian pharmaceutical and consumer health manufacturer whose herbal/OTC products compete directly with Tempo Scan's Indonesian consumer health portfolio in traditional trade and modern retail.
• Paragon Technology and Innovation (Wardah): Indonesian halal cosmetics leader behind Wardah, Make Over, and Emina, directly competing with Tempo Scan's MARINA, ULTIMA II, and Claudia cosmetics brands in the mass and mid-tier Indonesian beauty segment.
• PT Kimia Farma Tbk: State-affiliated Indonesian pharmaceutical manufacturer and retailer with overlapping OTC, prescription, and consumer health product lines, competing head-to-head with Tempo Scan's pharma portfolio in domestic distribution channels.

Broad incumbents

• PT Unilever Indonesia Tbk: Multinational consumer-goods giant with broad personal-care and cosmetics portfolio in Indonesia (Lifebuoy, Dove, Pond's, Citra) that competes with Tempo Scan's consumer and cosmetic brands while operating at much larger scale across many categories.
• PT Merck Tbk (Indonesia): Subsidiary of global pharma/healthcare company Merck operating in Indonesia across pharmaceuticals, consumer health, and life sciences, providing a multinational benchmark and partial overlap with Tempo Scan's prescription and OTC categories.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/filma-utama-soap-pt

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Filma Utama Soap Pt